CVS - CVS Health Corporation
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a...
CVS Health (CVS) closed at $81.36 in the latest trading session, marking a +2.56% move from the prior day.
UnitedHealth‘s stock has significantly lagged behind competitors like CVS and Centene over the previous year. A detailed examination indicates strong profitability, with an LTM Operating Margin of...
WOONSOCKET, R.I., Jan. 15, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Tuesday, February 10th, 2026, at 8:00 a.m.
Building on 18 months of proven success, the initiative will scale evidence-based solutions to improve pregnancy and postpartum outcomes for New Yorkers NEW YORK, Jan. 14, 2026 /PRNewswire/ -- The...
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
Gilead Sciences' new HIV prevention drug has been added to CVS Health's commercial insurance plans, the drugmaker's CEO Daniel O'Day said at a major industry conference that kicked off on Monday...
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Hennion and Walsh Asset Management Inc. purchased a new position in shares of CVS Health Corporation (NYSE: CVS) in the undefined quarter, according to its most recent filing with the Securities...
WOONSOCKET, R.I., Jan. 9, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, February 11th, 2026, at 8:00 a.m.
Building on a strong 2025, CVS Health's outlook for 2026 and beyond looks promising. Amgen is developing newer drug products that will address a recent patent cliff.
Stock News Trump targets Wall Street homebuying: President Trump proposed banning large institutional investors from purchasing single-family homes, sending sha
CVS Health (CVS) closed at $79.79 in the latest trading session, marking a -1.13% move from the prior day.
A new report from Hunterbrook Media investigates how the three biggest health care giants in the U.S.— CVS Health Corp. (NASDAQ:CVS), UnitedHealth Group, Inc. (NYSE:UNH) and Cigna Group (NYSE:CI)...
WOONSOCKET, R.I., Jan. 6, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents)...
Community Trust and Investment Co. decreased its position in CVS Health Corporation (NYSE: CVS) by 3.1% in the undefined quarter, according to the company in its most recent 13F filing with the...
CapWealth Advisors LLC cut its stake in shares of CVS Health Corporation (NYSE: CVS) by 2.4% in the third quarter, according to the company in its most recent filing with the Securities and...
Major closures on New Year's Day including stock markets and shipping carriers. Some stores will be open with adjusted hours. Banks and post offices resume regular service on Friday.